Tiansheng Pharmaceutical Group Co., Ltd.
SZSE:002872.SZ
4.97 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -93.713 | -91.553 | -72.339 | -493.585 | -218.939 | 117.507 | 255.811 | 234.044 | 201.299 | 173.871 | 133.025 | 113.205 |
| Depreciation & Amortization
| 107.26 | 107.722 | 89.992 | 117.053 | 106.063 | 108.502 | 94.712 | 74.05 | 65.657 | 59.818 | 49.335 | 34.745 |
| Deferred Income Tax
| -1.401 | 4.24 | 30.379 | -44.454 | -12.913 | -0.597 | -9.215 | -5.015 | 1.755 | 0 | 0 | 0 |
| Stock Based Compensation
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Working Capital
| -79.998 | 47.348 | -33.336 | 116.288 | 128.162 | -150.754 | -480.882 | 134.505 | -121.603 | -90.875 | -169.933 | -21.764 |
| Accounts Receivables
| 103.035 | 54.684 | -419.086 | 277.36 | 35.02 | 81.354 | -269.525 | 1.35 | -156.4 | 0.009 | -0.171 | -38.271 |
| Inventory
| 49.466 | -6.862 | 167.569 | -3.686 | 128.773 | 47.991 | -95.125 | 53.486 | -14.81 | -24.321 | -166.571 | -53.902 |
| Accounts Payables
| -231.098 | -4.714 | 187.803 | -112.932 | -23.476 | -183.77 | -77.436 | 84.684 | 47.852 | 0 | 0 | 0 |
| Other Working Capital
| 2.162 | 4.24 | 30.379 | -44.454 | -12.155 | -198.746 | -385.757 | 81.019 | -106.793 | -66.554 | -3.362 | 32.138 |
| Other Non Cash Items
| 17.232 | 25.669 | 34.654 | 449.998 | 128.921 | 78.732 | 74.61 | 64.078 | 68.186 | 49.174 | 44.632 | 18.872 |
| Operating Cash Flow
| -24.562 | 89.185 | 18.972 | 189.754 | 144.208 | 153.987 | -55.749 | 506.677 | 213.539 | 191.989 | 57.059 | 145.057 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| -76.738 | -73.421 | -114.383 | -92.7 | -93.239 | -234.269 | -862.247 | -425.959 | -274.874 | -330.322 | -126.345 | -184.63 |
| Acquisitions Net
| 15.054 | 22.453 | 31.078 | 7.1 | 3.537 | -39.235 | -4.302 | 0.063 | 0.166 | -46.968 | -8.496 | 0.65 |
| Purchases Of Investments
| -330 | -188 | -152.7 | -202.07 | -142.5 | -100 | -401 | 0 | -6.75 | -0.1 | -5 | -20.32 |
| Sales Maturities Of Investments
| 331.906 | 271.825 | 398.645 | 201.312 | 102.491 | 201.22 | 303.332 | 0.12 | 0.12 | 0.214 | 14.788 | 0.084 |
| Other Investing Activites
| -22.301 | -98.423 | 6.94 | 10.208 | 1.15 | 11.385 | 10.027 | 31.73 | 26.003 | 16.262 | -59.046 | 52.177 |
| Investing Cash Flow
| -82.08 | -65.567 | 169.58 | -76.15 | -128.562 | -160.899 | -954.19 | -394.108 | -255.334 | -360.914 | -184.099 | -152.039 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| -4.73 | -163.59 | -354.39 | -726.83 | -570.568 | -560.32 | -603.68 | -694.2 | -461.56 | -506.36 | -284.873 | -175.163 |
| Common Stock Issued
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| -15.537 | -15.939 | -22.895 | -37.19 | -34.749 | -93.013 | -34.34 | -35.983 | -31.097 | -37.237 | -29.55 | -19.399 |
| Other Financing Activities
| -0.396 | 135.057 | 238.315 | 629.448 | 571.527 | 379.723 | 1,871.016 | 798.768 | 572.302 | 730.166 | 482.049 | 235.467 |
| Financing Cash Flow
| -11.204 | -44.471 | -138.97 | -134.571 | -33.79 | -273.611 | 1,232.996 | 68.585 | 79.645 | 186.569 | 167.626 | 40.905 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0.024 | -0.131 | -0.125 | 0.118 | -0 | 0 | 0 | 0 |
| Net Change In Cash
| -117.845 | -20.853 | 49.582 | -20.967 | -18.12 | -280.654 | 222.932 | 181.272 | 37.85 | 17.644 | 40.587 | 33.923 |
| Cash At End Of Period
| 160.405 | 278.25 | 299.104 | 249.521 | 269.201 | 287.321 | 567.915 | 344.982 | 163.71 | 125.86 | 108.216 | 67.629 |